Health. By the end of 2017, the RACAF was comprised by 24 public and 34 private genetic counseling clinics spread in 11 provinces (http://www.msal.gob.ar/images/stories/ bes/graficos/0000001236cnt-20180705-reporte-anual-racaf-2017.pdf). In 2017, the SITHER (Hereditary Tumor Information System) was publicly launched by the RACAF as an open-access source of anonymized genomic and epidemiological information for Hereditary Cancers (SITHER website: https://bit.ly/2wLRHjX). The SITHER is a public repository containing the results of molecular studies (mainly NGS and MLPA) from over 500 argentine patients evaluated by RACAF (last accessed: August 2018).
It is also worth to mention other sources of academic translational research focused on genetics and genomics medicine. Finally, we would like to remark that several research/ clinical groups are using genomic approaches for the study and diagnosis of genetic disorders such as neurological disorders (Cordoba et al., 2018; Rodriguez-Quiroga et al., 2015) , Duchenne/Becker muscular dystrophy (Luce et al., 2018) , breast cancer (Solano et al., 2017 , ovarian cancer (Cardoso et al., 2018) , and endocrine/immune diseases (Gutierrez et al., 2018) , among others.
We believe that these data adds information to the article by Vishnopolska et al. We are also aware that there might be other public Institutions where genetic and genomic diagnosis and research are performed. We excluded all nonprofit and private laboratories on this report because this letter was intended to show only the public genetic and genomic medicine landscape in Argentina supported by Government funds. But it is of our knowledge that there are many nonprofit and private Institutions performing similar types of studies.
As a concluding remark, we agree with Vishnopolska et al. that Argentina is a big country with inequalities in the access to public health care, especially in medical genetics and genomics. We also agree that there are programs that aim
